TIKI2 suppresses growth of osteosarcoma by targeting Wnt/β-catenin pathway

Molecular and Cellular Biochemistry

Volumn 392, Issue 1-2, 2014, Pages 109-116

  Li, Ruhui ^a   Liu, Jianguo ^a   Wu, Hong ^a   Liu, Lidi ^a   Wang, Lijun ^a   Zhang, Shaokun ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

Osteosarcoma; TIKI; Wnt; Catenin

Indexed keywords

ADENOVIRUS VECTOR; BETA CATENIN; PROTEIN; TIKI 2 PROTEIN; UNCLASSIFIED DRUG; WNT PROTEIN; METALLOPROTEINASE; PRIMER DNA; TIKI2 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CELL INVASION; CELL PROLIFERATION; CELL SURVIVAL; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; OSTEOSARCOMA; OSTEOSARCOMA CELL; PROTEIN EXPRESSION; WNT SIGNALING PATHWAY; ANIMAL; BAGG ALBINO MOUSE; CELL DIVISION; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; TUMOR CELL LINE; TUMOR INVASION; XENOGRAFT;

ANIMALIA;

ANIMALS; BASE SEQUENCE; BETA CATENIN; CELL DIVISION; CELL LINE, TUMOR; CELL PROLIFERATION; DNA PRIMERS; HETEROGRAFTS; HUMANS; MALE; METALLOENDOPEPTIDASES; MICE; MICE, INBRED BALB C; NEOPLASM INVASIVENESS; OSTEOSARCOMA; POLYMERASE CHAIN REACTION; WNT SIGNALING PATHWAY;

EID: 84905180626     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-014-2023-5     Document Type: Article

References (22)

1. Bacci G, Briccoli A, Rocca M, Ferrari S, Donati D, Longhi A, Bertoni F, Bacchini P, Giacomini S, Forni C, Manfrini M, Galletti S (2003) Neoadjuvant chemotherapy for osteosarcoma of the extremities with metastases at presentation: recent experience at the Rizzoli Institute in 57 patients treated with cisplatin, doxorubicin, and a high dose of methotrexate and ifosfamide. Ann Oncol 14:1126-1134 (Pubitemid 36950179)
2. Li C, Shi X, Zhou G, Liu X, Wu S, Zhao J (2013) The canonical Wnt-beta-catenin pathway in development and chemotherapy of osteosarcoma. Front Biosci (Landmark Ed) 18:1384-1391
3. Hoang BH, Kubo T, Healey JH, Sowers R, Mazza B, Yang R, Huvos AG, Meyers PA, Gorlick R (2004) Expression of LDL receptor-related protein 5 (LRP5) as a novel marker for disease progression in high-grade osteosarcoma. Int J Cancer 109:106-111 (Pubitemid 38160669)
4. Chen K, Fallen S, Abaan HO, Hayran M, Gonzalez C, Wodajo F, MacDonald T, Toretsky JA, Uren A (2008) Wnt10b induces chemotaxis of osteosarcoma and correlates with reduced survival. Pediatr Blood Cancer 51:349-355
5. Lu BJ, Wang YQ, Wei XJ, Rong LQ, Wei D, Yan CM, Wang DJ, Sun JY (2012) Expression of WNT-5a and ROR2 correlates with disease severity in osteosarcoma. Mol Med Rep 5:1033-1036
6. Hoang BH, Kubo T, Healey JH, Yang R, Nathan SS, Kolb EA, Mazza B, Meyers PA, Gorlick R (2004) Dickkopf 3 inhibits invasion and motility of Saos-2 osteosarcoma cells by modulating the Wnt-beta-catenin pathway. Cancer Res 64:2734-2739 (Pubitemid 38500609)
7. Guo Y, Zi X, Koontz Z, Kim A, Xie J, Gorlick R, Holcombe RF, Hoang BH (2007) Blocking Wnt/LRP5 signaling by a soluble receptor modulates the epithelial to mesenchymal transition and suppresses met and metalloproteinases in osteosarcoma Saos-2 cells. J Orthop Res 25:964-971 (Pubitemid 47046444)
8. Guo Y, Rubin EM, Xie J, Zi X, Hoang BH (2008) Dominant negative LRP5 decreases tumorigenicity and metastasis of osteosarcoma in an animal model. Clin Orthop Relat Res 466:2039-2045
9. Kansara M, Tsang M, Kodjabachian L, Sims NA, Trivett MK, Ehrich M, Dobrovic A, Slavin J, Choong PF, Simmons PJ, Dawid IB, Thomas DM (2009) Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in mice. J Clin Invest 119:837-851
10. Liu Y, Wang W, Xu J, Li L, Dong Q, Shi Q, Zuo G, Zhou L, Weng Y, Tang M, He T, Luo J (2013) Dihydroartemisinin inhibits tumor growth of human osteosarcoma cells by suppressing Wnt/beta-catenin signaling. Oncol Rep 30:1723-1730
11. Lin CH, Guo Y, Ghaffar S, McQueen P, Pourmorady J, Christ A, Rooney K, Ji T, Eskander R, Zi X, Hoang BH (2013) Dkk-3, a secreted wnt antagonist, suppresses tumorigenic potential and pulmonary metastasis in osteosarcoma. Sarcoma 2013:147541
12. Xu J, Zhu X, Wu L, Yang R, Yang Z, Wang Q, Wu F (2012) MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/beta-catenin pathway. Liver Int 32:752-760
13. Yan K, Gao J, Yang T, Ma Q, Qiu X, Fan Q, Ma B (2012) MicroRNA-34a inhibits the proliferation and metastasis of osteosarcoma cells both in vitro and in vivo. PLoS One 7:e33778
14. Nakashima N, Huang CL, Liu D, Ueno M, Yokomise H (2010) Intratumoral Wnt1 expression affects survivin gene expression in non-small cell lung cancer. Int J Oncol 37:687-694
15. Wilkins JA, Sansom OJ (2008) C-Myc is a critical mediator of the phenotypes of Apc loss in the intestine. Cancer Res 68:4963-4966
16. Cruciat CM, Niehrs C (2013) Secreted and transmembrane wnt inhibitors and activators. Cold Spring Harb Perspect Biol 5:a015081
17. Zhang X, Abreu JG, Yokota C, MacDonald BT, Singh S, Coburn KL, Cheong SM, Zhang MM, Ye QZ, Hang HC, Steen H, He X (2012) Tiki1 is required for head formation via Wnt cleavageoxidation and inactivation. Cell 149:1565-1577
18. Wang B, Liu J, Ma LN, Xiao HL, Wang YZ, Li Y, Wang Z, Fan L, Lan C, Yang M, Hu L, Wei Y, Bian XW, Chen D, Wang J (2013) Chimeric 5/35 adenovirus-mediated Dickkopf-1 overexpression suppressed tumorigenicity of CD44(+) gastric cancer cells via attenuating Wnt signaling. J Gastroenterol 48:798-808
19. McQueen P, Ghaffar S, Guo Y, Rubin EM, Zi X, Hoang BH (2011) The Wnt signaling pathway: implications for therapy in osteosarcoma. Expert Rev Anticancer Ther 11:1223-1232
20. Navarro D, Agra N, Pestana A, Alonso J, Gonzalez-Sancho JM (2010) The EWS/FLI1 oncogenic protein inhibits expression of the Wnt inhibitor DICKKOPF-1 gene and antagonizes betacatenin/TCF-mediated transcription. Carcinogenesis 31:394-401
21. Zhang F, Chen A, Chen J, Yu T, Guo F (2011) SiRNA-mediated silencing of beta-catenin suppresses invasion and chemosensitivity to doxorubicin in MG-63 osteosarcoma cells. Asian Pac J Cancer Prev 12:239-245
22. Li C, Cheng Q, Liu J, Wang B, Chen D, Liu Y (2012) Potent growth-inhibitory effect of TRAIL therapy mediated by doubleregulated oncolytic adenovirus on osteosarcoma. Mol Cell Biochem 364:337-344